INS and Alzheimer disease: Our studies showed that elderly persons with T2D treated with insulin plus other hypoglycemic agents (i.e., combination therapy) have dramatically less AD neuropathology (reduced densities of neuritic plaques and neurofibrillary tangles in the cortex) than otherwise similar non-T2D persons2.